4.8 Article

RNA editing of Filamin A pre-mRNA regulates vascular contraction and diastolic blood pressure

Journal

EMBO JOURNAL
Volume 37, Issue 19, Pages -

Publisher

WILEY
DOI: 10.15252/embj.201694813

Keywords

adenosine deaminases acting on RNA (ADAR); cardiovascular disease; Filamin A (FLNA); hypertension; RNA editing

Funding

  1. Austrian Science Foundation [F4313, P22956, P27166-B23, W1207]
  2. Mahlke-Obermann Stiftung
  3. European Union [609431]
  4. EC [QLG1-CT-2001-00869, LSHC-CT-2006-037731]
  5. Austrian Federal Government's GEN-AU program Austromouse [GZ 200.147/1-VI/1a/2006]
  6. Austrian Science Fund [FWF-P18421, FWF-P18782, SFB-23-B13, DK W1212]
  7. European Research Council [311257]
  8. Israel Science Foundation [1380/14]
  9. German Federal Ministry of Education and Research [01KX1012]
  10. Austrian Science Fund (FWF) [P27166, P26882, P22956, W1207] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

Epitranscriptomic events such as adenosine-to-inosine (A-to-I) RNA editing by ADAR can recode mRNAs to translate novel proteins. Editing of the mRNA that encodes actin crosslinking protein Filamin A (FLNA) mediates a Q-to-R transition in the interactive C-terminal region. While FLNA editing is conserved among vertebrates, its physiological function remains unclear. Here, we show that cardiovascular tissues in humans and mice show massive editing and that FLNA RNA is the most prominent substrate. Patient-derived RNA-Seq data demonstrate a significant drop in FLNA editing associated with cardiovascular diseases. Using mice with only impaired FLNA editing, we observed increased vascular contraction and diastolic hypertension accompanied by increased myosin light chain phosphorylation, arterial remodeling, and left ventricular wall thickening, which eventually causes cardiac remodeling and reduced systolic output. These results demonstrate a causal relationship between RNA editing and the development of cardiovascular disease indicating that a single epitranscriptomic RNA modification can maintain cardiovascular health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available